The impact of endpoint measures in rheumatoid arthritis clinical trials
References (64)
- et al.
Auranofin Cooperating Group: Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial
Am J Med
(1986) - et al.
Efficacy of tests used to monitor rheumatoid arthritis
Lancet
(1989) - et al.
Clinical evaluation in rheumatic diseases
- et al.
Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials
Arthritis Rheum
(1990) - et al.
Selection and combination of outcome measures
J Rheumatol
(1982) - et al.
Judging disease activity in clinical practice in rheumatoid arthritis: First step in the development of a disease activity score
Ann Rheum Dis
(1990) - et al.
Cooperative Systematic Studies of Rheumatic Diseases Group: Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs based on the findings in patients treated with placebo
Arthritis Rheum
(1990) - et al.
Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis
Br J Rheumatol
(1990) - et al.
The assessment of disease activity in rheumatoid arthritis using a multivariate analysis
Rheumatol Rehabil
(1981) - et al.
Measurement of patient outcome in arthritis
Arthritis Rheum
(1980)
Measuring health status in arthritis: The Arthritis Impact Measurement Scale
Arthritis Rheum
(1980)
Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures
Ann Intern Med
(1989)
1958 revision of diagnostic criteria for rheumatoid arthritis
Bull Rheum Dis
(1958)
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
Arthritis Rheum
(1988)
Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study
Br J Rheumatol
(1990)
Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind, placebo controlled study
J Rheumatol
(1988)
Clinical and laboratory outcomes during the treatment of rheumatoid arthritis with methotrexate
Scand J Rheumatol
(1990)
A three year follow up of patients allocated to placebo, or orally or injectable gold therapy for rheumatoid arthritis
Ann Rheum Dis
(1986)
Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritis
Rheumatol Int
(1989)
Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis
J Rheumatol
(1988)
Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis
J Rheumatol
(1989)
Combined d-penicillamine and chloroquine treatment of rheumatoid arthritis—A comparative study
Br J Rheumatol
(1987)
Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial
Arthritis Rheum
(1987)
Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study
Scand J Rheumatol
(1987)
Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis
Lancet
(1989)
Sensitivity of a Dutch health assessment questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine
Scand J Rheumatol
(1990)
Auranofin or d-penicillamine in the treatment of rheumatoid arthritis
Ann Intern Med
(1986)
Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study
Scand J Rheumatol
(1989)
Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation
Scand J Rheumatol
(1986)
Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis—A randomized, double blind 26-week trial
J Rheumatol
(1989)
A prospective five-year comparison of treatment which included penicillamine with that excluding penicillamine in early rheumatoid arthritis
Br J Rheumatol
(1986)
A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: Evidence of an earlier effect of sulphasalazine
Ann Rheum Dis
(1989)
Cited by (0)
- 1
From the cooperating Departments of Rheumatology of the University Hospital, Utrecht; St Antonius Hospital, Nieuwegein; Diakonessen Hospital, Utrecht; and Eemland Hospital, Amersfoort, the Netherlands.
- 2
Dr van der Heide's research is funded by the “Nationaal Reumafonds” (Dutch Arthritis Foundation).
Copyright © 1992 Published by Elsevier Inc.